No abstract available
Keywords:
COVID-19; chronic glomerulonephritis; immunology; immunosuppression; lymphocytes; nephrotic syndrome; rheumatology.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
Coronavirus Infections / immunology
-
Coronavirus Infections / prevention & control
-
Coronavirus Infections / transmission
-
Coronavirus Infections / virology*
-
Female
-
Humans
-
Immunocompromised Host*
-
Immunosuppressive Agents / adverse effects*
-
Male
-
Nephrotic Syndrome / diagnosis
-
Nephrotic Syndrome / drug therapy*
-
Nephrotic Syndrome / immunology
-
Opportunistic Infections / immunology
-
Opportunistic Infections / prevention & control
-
Opportunistic Infections / transmission
-
Opportunistic Infections / virology*
-
Pandemics / prevention & control
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / prevention & control
-
Pneumonia, Viral / transmission
-
Pneumonia, Viral / virology*
-
Prospective Studies
-
Randomized Controlled Trials as Topic
-
Recurrence
-
Risk Assessment
-
Risk Factors
-
Rituximab / adverse effects*
-
SARS-CoV-2
-
Time Factors
-
Treatment Outcome
-
Young Adult
Substances
-
Immunosuppressive Agents
-
Rituximab